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Abstract 
Objective: The aims of this study were to evaluate serum levels of acute phase reactants, 
such as CRP and cytokines (TNF-α and IL-6) in patients who have undergone thoracotomy 
and to investigate the effects of flurbiprofen on postoperative inflammatory response.  
Methods: Forty patients undergoing posterolateral thoracotomy were randomly divided into 
2 groups of 20 each. Control group received tramadol (4 x 100 mg) intravenously for four 
days, and flurbiprofen group received both tramadol (4 x 100 mg) and flurbiprofen (2 x 100 
mg). Blood samples were collected before surgery and at the 3th and 168th hours after 
surgical procedure to measure serum CRP, IL-6, and TNF-α. Pain visual analog scales were 
recorded daily during the first four postoperative days. Spirometric measurement of forced 
expiratory volume in the first second (FEV 1) was done before and four days after the op-
eration. 
 Results: The serum CRP, IL-6, and TNF-α levels in both groups increased significantly at 3th 
hour after thoracotomy. Serum TNF-α levels did not differ significantly between the groups at 
postoperative 4th day. However, IL-6 and CRP were significantly lower in flurbiprofen group 
than in control group at the same day (p<0.05). Visual analog scale was significantly lower in 
flurbiprofen group at 6th, 12th, 48th, 72th, and 96th hours postoperatively (p<0.05). The 
patients receiving flurbiprofen had higher FEV 1 values when compared with control group at 
postoperative 4th day. 
Conclusions: Patients undergoing thoracotomy showed reduced postoperative pain, mean 
additional analgesic consumption, and serum IL-6 and CRP levels, when flurbiprofen was 
added to systemic analgesic therapy. Analgesia with anti-inflammatory drug may contribute to 
the attenuation of the postoperative inflammatory response and prevent postoperative pain in 
patients undergoing thoracotomy. 
Key words: Thoracotomy pain, Inflammatory response, Flurbiprofen 
Introduction 
Surgical trauma induces an inflammatory state 
characterized by the release of both proinflammatory 
and antiinflammatory proteins. Proinflammatory cy-
tokines induce not only a local inflammation at the 
site  of  injury,  but  also  systemic  responses  such  as 
tachycardia, tachypnea, leukocytosis, and pyrexia (1). 
Increased  levels  of  proinflammatory  cytokines  are 
also associated with a higher incidence of postopera-Int. J. Med. Sci. 2011, 8 
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tive infections and respiratory failure (2-4). Attenua-
tion  of  the  inflammatory  response  can  reduce  inju-
ry-induced  immunosuppression  and  is  linked  to 
functional recovery (5). 
Nonsteroidal antiinflammatory drugs (NSAIDs) 
are useful in pain states, and work by inhibiting the 
cyclooxygenase enzyme responsible for the release of 
mediators of inflammation (6). The aims of this study 
were to evaluate the serum levels of acute phase re-
actants, such as C-reactive protein (CRP), and cyto-
kines (interleukin-6 (IL-6) and tumor necrosis factor-α 
(TNF-α)) in patients with thoracotomy and to inves-
tigate  the  effects  of  flurbiprofen  on  postoperative 
inflammatory response. 
Material and Methods 
Eligibility criteria 
Forty patients undergoing elective lung resection 
were  included  in  this  double-blind,  randomized 
study.  Ethical  approval  was  provided  by  the  ethics 
committee of Meram Medical School, Selcuk Univer-
sity, Konya, Turkey, and all patients gave their writ-
ten informed consent to participate in the study. Ex-
clusion criteria of the patients were as follows: history 
of severe heart disease (New York Heart Association 
class  IV  heart  failure  within  the  six  months  before 
enrollment)  or  hepatic  (Cirrhosis)  or  renal  failure 
(Chronic kidney disease need for renal replacement 
therapy) or peptic ulcus, American Society of Anes-
thesiology  class  IV  or  higher,  patients  undergoing 
resection of the pleura or chest wall, and patients with 
hemorrhagic  diathesis  or  medication  of  anticoagu-
lants, corticosteroids, and acetylsalisilic acid. 
The surgical approach in all the patients was a 
posterolateral  thoracotomy  through  the  5th  inter-
costals space, usually extended from the midscapular 
to the anterior axillary line for a length ranging be-
tween 12 and 15 cm. 
Experimental protocol 
Two  randomized  groups  of  20  patients  each 
were compared. The baseline pain medication in both 
groups was tramadol (4 x 100 mg) intravenously for 
four days. Control group received tramadol (4 x 100 
mg)  intravenously  for  four  days  and  flurbiprofen 
group  received  both  tramadol  (4  x  100  mg)  and 
flurbiprofen (2 x 100 mg). Paracetamol 1000 mg was 
administered as an additional analgesic, if required, 
for two groups.  
Postoperative care 
Demographic  information,  visual  analog  pain 
scores, pulmonary function tests, and supplementary 
intravenous analgesia were recorded for each patient. 
Patients subjectively assessed the level of pain at 1th, 
6th, 12th, 24th, 48th, 72th, and 96th hours after sur-
gery  by  a  visual  analogue  scale  (VAS)  with  scores 
ranging between 1 (pain free) and 10 (the worst im-
aginable  pain).  Pulmonary  function  parameter  in-
cluding forced expiratory volume in the first second 
(FEV 1) was performed preoperatively and at post-
operative 4th day. Operation time, number of chest 
tubes,  length  of  hospital  stay,  and  postoperative 
complications were recorded in all patients. 
Measurement of inflammatory mediators 
Blood samples were collected before surgery and 
at 3 and 96 hours after surgical procedure to measure 
serum CRP, IL-6, and TNF-α levels. Peripheral venous 
blood samples were collected into the blood collector 
tubes  (Vacuette,  Greiner  Bio-One  GmbH  Ba-
den-Württemberg, Germany) and than centrifuged at 
4.500 rpm for 10 minutes (Eppendorf Centrifuge 5702, 
Eppendorf Ag, Hamburg Germany), and sera samples 
were  obtained.  All  the  following  laboratory  assays 
were performed by using obtained sera; high sensitive 
CRP (mg/L), IL-6 (pg/mL) and TNF-α (pg/mL). High 
sensitive CRP mesurement performed with nephelo-
metric method (reactive: Dade Behring GmbH Mar-
burg, Germany, device: BN II Dade Behring GmbH 
Marburg, Germany), IL-6 (Invitrogen Corp. CA, USA) 
and TNF- α (Invitrogen Corp. CA, USA) assays per-
formed by using enzyme linked immuno sorbent as-
say method (ELISA) (Tecan Minilyser, Tecan Group 
Ltd. Mannedorf, Switzerland). IL-6 and TNF- α assay 
mesurements were carried out at 450 nm optical den-
sity (OD). 
Statistical analysis 
All parametric results were expressed as mean ± 
standard deviation for each group. Statistical analysis 
was performed with SPSS 15.0 software. Fisher’s exact 
test was used to analyze between-group differences in 
categorical variables. Student’s t-test was used to as-
sess between-group differences in continuous varia-
bles. A p-value less than 0.05 was considered to be 
statistically significant. 
Results 
Forty  patients  fulfilled  the  study  criteria  and 
were therefore included in the trial. All patients un-
derwent lung resection either for lung cancer or be-
nign  disease.  There  were  no  significant  differences 
between groups regarding age, sex, reasons of thora-
cotomy, preoperative FEV 1, number of chest tubes, 
operation time, and postoperative blood loss (Table 
1). 
Visual  analog  scale  was  significantly  lower  in Int. J. Med. Sci. 2011, 8 
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flurbiprofen group at 6th, 12th, 48th, 72th, and 96th 
hours postoperatively (p<0.05) (Figure 1). Mean addi-
tional  analgesic  consumption  (paracetamol  clorhy-
drate,  1000  mg  infusion  solution)  in  the  96th  hour 
after surgery was 775 mg for control group and 200 
mg  for  flurbiprofen  group.  There  were  significant 
differences between control and flurbiprofen groups 
(p<0.05).  
 
Table 1. Patient characteristics, reasons for thoractomy, and surgical information 
  Flurbiprofen group  Control group 
Median age (years)  55.3  50.4 
Sex ratio (M/F)  13/7  12/8 
Preoperative FEV1(% predict)  65.6  64.6 
Number of chest tubes (1/2 tube)  9/11  6/14 
Operation time (min)  150  156 
Postoperative blood loss (ml)  266  249 
Adenocarcinoma (n)  5  4 
Squamous carcinoma (n)  7  5 
Large cell carcinoma (n)  1  3 
Carsinoid tumor (n)  0  1 
Bronchiectasis (n)  4  4 
Hydatid cyst (n)   1  1 
Metastasis (n)  2  2 
 
 
 
 
Figure 1. Postoperative pain scores as assessed by Visual Analogue Scale in the study groups. 
 
 
Postoperative increases in serum CRP, IL-6, and 
TNF-α concentrations were observed in both groups. 
The CRP value peaked on the postoperative 4th day in 
the  control  group  whereas  IL-6  and  TNF-α  values 
peaked on the postoperative 1th day in both groups. 
Serum CRP, IL-6, and TNF-α levels did not differ sig-
nificantly  between  the  groups  at  preoperative  and 
postoperative first day. Serum TNF-α levels were not 
significantly different between the groups at postop-
erative 4th day. However, IL-6 and CRP were signifi-
cantly  lower  in  flurbiprofen  group  than  in  control 
group at postoperative 4th day (Figure 2,3,4).  
Mean postoperative length of hospital stay was 
8.0±2.2  days  in  control  group  and  6.8±1.9  days  in 
flurbiprofen group. There were no significant differ-
ences  between  the  both  groups  (p=0.077).  Mean 
postoperative (%) FEV 1 was 49.7±7.2 in control group 
and 55.6±6.7 in flurbiprofen group. There were sig-
nificant differences between the both groups (p<0.05). 
No major complication occurred in any groups. Pro-Int. J. Med. Sci. 2011, 8 
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longed chest tube drainage occurred in one patient in 
the  flurbiprofen  group.  Atelectasis  occurred  in  one 
patient belonging to the control group and it was re-
covered  by  respiratory  rehabilitation  and  broncho-
scopic aspiration. Gastrointestinal side effects, mostly 
nausea and vomiting, were determined as the most 
common events in both groups. No patients in both 
groups discontinued the study because of severe side 
effects (Table 2). 
 
 
 
 
 
Figure 2. Changes in serum concentration of TNF-α be-
fore and after thoracotomy in the study groups. 
 
 
 
 
Figure 3. Changes in serum concentration of IL-6 before 
and after thoracotomy in the study groups. 
 
Figure 4. Changes in serum concentration of CRP before 
and after thoracotomy in the study groups. 
 
 
Table 2. Side effects and complications in the postopera-
tive period. 
Side effects   Flurbiprofen 
group (n, %) 
Control 
group (n, %) 
Prolonged chest tube drainage  1(5)  - 
Atelectasis  -  1 (5) 
Nausea/vomiting  9 (45)  7 (35) 
Constipation  2 (10)  3 (15) 
 
 
Discussion  
Thoracotomy  for  lung  resection  represents  a 
major surgical stress, and is associated with a signifi-
cant increase in the postoperative circulating levels of 
plasma inflammatory markers (7). Our results showed 
that the levels of serum CRP, IL-6, and TNF-α were 
high in all patients after surgery, and that CRP and 
IL-6 elevations were significantly less pronounced in 
the group using anti-inflammatory drug than control 
group. In addition, patients in the flurbiprofen group 
experienced less severe postoperative pain, whereas 
those in the control group reported higher VAS scores 
and additional analgesic consumption. These findings 
may  be  related  to  the  antiinflammatory  effects  of 
flurbiprofen. 
VAS scoring is a simple and often used method 
for evaluating variations in pain intensity. Subjects are 
instructed  to  indicate  the  intensity  of  the  pain  by 
marking a 100-mm line anchored with terms describ-
ing the extremes of pain intensity. VAS scoring was a 
valid measure of pain in the early postoperative pe-
riod  (8).  VAS  scoring  was  used  for  evaluating  acut 
postthoracotomy pain in different studies (9-12).  
Systemic cytokine response induced by surgical 
damage has been reported and is thought to have an 
important  effect  on  the  immune  system.  IL-6  and 
TNF-α are major mediators of the acute-phase protein Int. J. Med. Sci. 2011, 8 
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response to tissue damage caused by surgical inter-
vention (13-15). CRP is an acute phase reactant; it is a 
marker of inflammation and produced in the liver on 
stimulation  by  monocyte  related  cytokines,  such  as 
IL-6 and TNF-α. (16,17). Among the human body re-
sponses to surgery, the serum IL-6 level is reported to 
be a sensitive indicator of the degree of surgical stress 
(13-15). Furthermore, it has been reported that post-
operative  IL-6  levels  correlate  with  postoperative 
complications and mortality (18). Many reports con-
firm our finding that IL-6 concentration in the control 
group on postoperative first day after pulmonary re-
section over 100 pg/ml (2,19,20). 
 While IL-6 level reached to the peak level at the 
postoperative first day in the both group, it was found 
statistically lower at flurbiprofen administrated group 
comparing with control group on postoperative 4th 
day.  While  the  IL-6  levels  determined  at  reference 
value  in  flurbiprofen  group,  it  was  remained  over 
reference range in control group at postoperative 4th 
day. While TNF-α measurement reached to the peak 
level in both group on postoperative 4th day, levels of 
TNF-  α  were  determined  relatively  lower  at  flurbi-
profen group comparing with control group. In addi-
tion  to  this,  there  was  no  significant  difference  be-
tween two groups. Serum CRP level was significantly 
lower in flurbiprofen group than in control group at 
postoperative 4th day. 
Pain control is a significant concern in hospital-
ized patients, with many clinicians now considering 
pain to be the fifth vital sign (21). Colacchio et al. (22) 
reported that ketorolac may be an effective agent for 
restoring perioperative immune competence, whereas 
the use of continuous morphine might have signifi-
cant deleterious effects. Torres et al. (23) reported that 
postoperative pain after abdominal surgery in which 
dipyrone administered via patient controlled analge-
sia pumps had the same analgesic efficacy with less 
adverse  effects  than  buprenorphine  and  morphine. 
Although in most cases NSAIDs can control postop-
erative pain after ambulatory surgery, NSAIDs alone 
are usually insufficient during the early postoperative 
period  in  hospitalized  patients  undergoing  major 
surgical procedures (24). NSAIDs are associated with 
inhibition  of  platelet  aggregation,  gastrointestinal 
bleeding, and renal toxicity, limiting their usefulness 
in clinical practice. The incidence of these side effects 
are  rare,  however,  patients  with  preexisting  peptic 
ulcer disease and renal impairment are at greater risk. 
Careful patient selection, therefore, would seem to be 
the  prudent  course  of  action  when  choosing  these 
agents perioperatively. 
Lung  volumes  after  thoracic  surgery  may  be 
reduced  by  up  to  50%,  and  aggressive  analgesic 
therapy  leads  to  improvements  in  pulmonary  func-
tion not observed with standard therapy (25-27). The 
pain relief in the flurbiprofen group resulted in better 
function  with  higher  postoperative  FEV1.  When 
comparing preoperative and postoperative measured 
FEV 1 values, 24 % and 16 % decreases determined at 
control and flurbiprofen groups, respectively. 
In conclusion, we observed that patients under-
going  thoracotomy  showed  reduced  postoperative 
pain,  mean  additional  analgesic  consumption,  and 
serum IL-6 and CRP levels, when flurbiprofen added 
to  the  systemic  analgesic  therapy.  Analgesia  with 
antiinflammatory drug may contribute to the attenu-
ation of the postoperative inflammatory response and 
prevent  postoperative  pain  in  patients  undergoing 
thoracotomy. 
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